Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MITOMYCIN FOR INJECTION | 20MG | POWDER FOR SOLUTION | Actual shortage | 2018-11-01 | 2021-10-14 | 65987 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68626 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68629 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68632 |
TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2019-01-08 | 2020-04-02 | 71550 |
TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-06-13 | 2019-12-19 | 86611 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86914 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86917 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86920 |
TEVA-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86957 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2019-07-02 | 2019-08-06 | 88186 |
TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2019-08-22 | 2020-05-14 | 92186 |
TEVA-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-22 | 2020-04-16 | 92238 |
TEVA-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-22 | 2020-02-07 | 92241 |
TEVA-TAMOXIFEN | 20MG | TABLET | Resolved | 2019-09-19 | 2020-05-14 | 94381 |
TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94867 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94877 |
TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2019-11-14 | 2020-01-17 | 98738 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Resolved | 2019-11-21 | 2020-01-24 | 99444 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99974 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |